The anti-obesity effect of the absence of iNOS is probably due to changes in pathways promoting the differentiation of brown fat cells, and changes in genes involved in brown fat function, such as Sirt1, Sirt-3 and Pgc-1α. The gene discussed is SIRT3; the disease is obesity due to melanocortin 4 receptor deficiency.